Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Azenta Inc.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on COMPASS Pathways (CMPS), Geron (GERN) and Azenta (AZTA). COMPASS ...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	AZTA	$31.98	+4.03%	410.01K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	AZTA	$31.98	+4.0%	410.01K
3
4
5
6

AZTA

AZTA

Get Azenta Inc. Data in Excel

Get Azenta Inc. Data in Excel